Laura Edgerly-Pflug
Plus aucun poste en cours
Profil
Laura Edgerly-Pflug formerly worked at The Liposome Co., Inc., as Principal, Insmed, Inc., as VP-Technical Operations & Chemistry from 2012 to 2013, OVATION Pharmaceuticals, Inc., as Principal, Lyra Therapeutics, Inc., as Senior Vice President-Technical Operations from 2019 to 2020, Adgero Biopharmaceuticals Holdings, Inc., as VP-Manufacturing Operations & Quality Control from 2016 to 2019, and Pflug Biopharm Solutions LLC, as Owner from 2014 to 2016.
Ms. Edgerly-Pflug received her undergraduate degree from Kean University.
Anciens postes connus de Laura Edgerly-Pflug
| Sociétés | Poste | Fin |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 24/07/2020 |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Corporate Officer/Principal | 01/06/2019 |
| Pflug Biopharm Solutions LLC | Corporate Officer/Principal | 01/09/2016 |
| INSMED INCORPORATED | Corporate Officer/Principal | 01/12/2013 |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Corporate Officer/Principal | - |
Formation de Laura Edgerly-Pflug
| Kean University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Health Technology |
| Pflug Biopharm Solutions LLC |
